This test is most useful if any of these apply to you.
Your body runs on a constant tug-of-war between stress hormones that break tissue down and recovery hormones that build it back up. DHEA-S (dehydroepiandrosterone sulfate) is one of the most abundant hormones in your blood and serves as the main counterweight to cortisol, the hormone your adrenal glands release under pressure. Measuring it in saliva gives you a non-invasive window into adrenal output and stress-recovery balance.
Salivary DHEA-S sits in a different category than your standard hormone panel. It is a research-oriented measurement without universally standardized cutpoints, so a single reading is best treated as a baseline to track over time rather than a yes-or-no diagnosis. What it offers is an early, exploratory view of how your adrenal glands and stress axis are functioning, often paired with cortisol to assess resilience.
DHEA-S is the sulfate version of DHEA, a steroid hormone made almost entirely in the outer layer of your adrenal glands (the zona reticularis). Your body converts cholesterol into DHEA, then attaches a sulfate group to create DHEA-S, which lasts much longer in circulation than DHEA itself. From there, your tissues can convert it into more potent sex hormones, including testosterone and estradiol, depending on where it ends up.
Levels peak in early adulthood and decline steadily with age, which is why DHEA-S is sometimes called an aging-related hormone. It is also one of the most abundant circulating steroids in healthy adults, and it tends to work in opposition to cortisol, supporting immune balance and tissue repair. The cortisol-to-DHEA-S ratio is often used as a marker of stress resilience or vulnerability.
Most of the published clinical research on DHEA-S uses blood. Salivary DHEA-S is a newer approach that captures the hormone in a non-invasive sample you can collect at home. Across multiple adult samples, salivary DHEA-S shows a clear pattern across the day, with the highest values around awakening and a gradual decline through the day. Blood and saliva measurements give broadly comparable results for tracking acute stress responses, though they are not identical assays.
Because salivary DHEA-S lacks universally standardized clinical cutpoints, it is most useful as a serial measurement that you trend against your own baseline, rather than a single number to compare against a population average. Much of the disease-association evidence below comes from blood-based DHEA-S studies, which provide context for what abnormal levels can signify biologically.
Acute mental or physical stress causes a short-term rise in DHEA in both blood and saliva that peaks at the end of the stressor and returns to baseline within about an hour. Athletes exposed to high-altitude environmental stress also show increased salivary DHEA-S and cortisol after exercise. This rapid responsiveness is why DHEA is considered a validated acute stress biomarker.
Chronic stress tells a different story. In shift-working healthcare professionals tracked over six months, increased DHEA-S alongside reduced cortisol was linked to worsening sleep disturbance and impairment. In family caregivers of people with dementia, participation in adult day services that reduced daily stress was associated with higher next-day salivary DHEA-S and improved positive mood. The pattern that matters here is not just the level but how DHEA-S moves in relation to cortisol over time.
In recurrent depression, altered diurnal DHEA-S patterns and altered cortisol-to-DHEA-S ratios in saliva appear trait-like and have been shown to predict time to recurrence over ten years of follow-up. Morning salivary DHEA was the only neuroendocrine marker that separated depressed patients with a prior history of depression from those experiencing a first episode in one HPA-axis challenge study, suggesting it may track underlying vulnerability rather than current state.
In adolescent girls, higher salivary DHEA was associated with more anxiety symptoms and higher odds of anxiety disorders, particularly generalized anxiety disorder, in a sample of 286 participants. The relationship between DHEA-S and mood is complex and bidirectional, and a single elevated or low reading should not be interpreted as a psychiatric diagnosis.
The strongest disease-association evidence comes from serum, not salivary, DHEA-S. A meta-analysis of 25 cohorts covering 92,489 cardiovascular disease patients found that those in the lowest serum DHEA-S category were about 47% more likely to die from any cause (relative risk 1.47), about 58% more likely to have a fatal cardiovascular event (RR 1.58), and about 42% more likely to have a nonfatal cardiovascular event (RR 1.42) compared with those in the highest category. Most studies adjusted for age, smoking, blood pressure, lipids, diabetes, body mass index, and inflammation.
A meta-analysis of 359,047 participants across multiple cohorts found that men in the highest serum DHEA-S tertile had about 28% lower all-cause mortality than men in the lowest tertile (hazard ratio 0.72). The association was not seen in women. Salivary DHEA-S has not been directly tested for hard outcomes like this, so these blood-based findings provide biological context rather than direct evidence about the saliva measurement.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| About 2,600 men aged 69 to 81, followed 4.5 years | Lowest quarter vs higher of serum DHEA-S | About 54% higher risk of all-cause death and 61% higher risk of cardiovascular death |
| About 8,100 older adults with no baseline heart disease, followed 18 years | Lowest 15th percentile vs higher of serum DHEA-S | About 30 to 42% higher heart failure risk in men and women |
| About 4,200 US veterans followed 15 years | Higher vs lower serum DHEA-S and cortisol-to-DHEA-S ratio | Higher DHEA-S linked to lower all-cause, cancer, and other medical mortality; higher cortisol-to-DHEA-S linked to higher risk |
Sources: MrOS Sweden (Ohlsson et al.), ARIC (Jia et al.), Vietnam Experience Study (Phillips et al.). What this means for you: the cardiovascular mortality evidence comes from serum DHEA-S in older adults, and the saliva-based equivalent has not been established. Trending your salivary DHEA-S can still flag a pattern of declining adrenal output worth investigating, but you should not extrapolate a single low reading to a specific cardiovascular risk number.
Aging is associated with lower salivary DHEA, a flatter daily decline, and a higher cortisol-to-DHEA ratio. In older adults specifically, flatter DHEA rhythms have been linked to poorer physical function and independence. The decline is biologically meaningful: DHEA-S falls substantially from young adulthood through later life, which is part of why it draws interest in longevity research.
In women, higher endogenous serum DHEA-S was independently associated with better executive function, concentration, and working memory in a study of 295 participants. Higher salivary DHEA responses to cognitive load have also been linked to better electrophysiological markers of working memory and less distraction in smaller experimental work.
Very low DHEA-S can signal adrenal insufficiency, where the adrenal glands fail to produce enough hormones. In Addison's disease, near-total failure of adrenal DHEA production means DHEA-S levels drop to almost nothing, and replacement therapy raises them and can modestly improve bone density and well-being. Reduced DHEA-S has also been documented in primary Sjögren's syndrome, an autoimmune condition that attacks the salivary and tear glands.
On the other side, elevated DHEA-S can suggest enhanced adrenal androgen production, including premature adrenarche in children, some adrenal tumors, and certain cases of congenital adrenal hyperplasia. In adrenal incidentalomas (tumors found incidentally on imaging), low serum DHEA-S is a sensitive screen for subclinical cortisol excess. None of these conditions are typically diagnosed by saliva alone, but a pattern of persistently low or high salivary DHEA-S can be reason to investigate further with blood-based testing.
Salivary DHEA-S has notable day-to-day variability, and a single number can be misleading. The hormone follows a clear circadian rhythm, with highest values near awakening and a decline through the day, so sample timing matters enormously. What gives you signal is the trajectory: how your level changes across months, how steeply it declines with age, and how it shifts in response to stress, sleep, and lifestyle interventions you make.
A trajectory analysis in older adults followed for a median of nearly 11 years found that a steep decline in DHEA-S over time was associated with about 75% higher mortality risk, and extreme variability with about 89% higher risk, while baseline level alone was not predictive. Translation: how DHEA-S moves matters more than a snapshot. A reasonable cadence is a baseline measurement, a follow-up at three to six months if you are actively changing your stress, sleep, or exercise habits, and at least annual tracking after that.
Because salivary DHEA-S is a research-tier marker without standardized clinical thresholds, getting your own baseline now is valuable. As the science matures, you will have your own data to compare against, rather than starting from zero.
A single out-of-pattern salivary DHEA-S should not drive a clinical decision in isolation. The first step is to retest with strict attention to timing, collection technique, and any acute stress or fasting in the hours before the sample. If the pattern persists across two or three carefully collected samples, the next step is usually a serum DHEA-S measurement, since blood-based assays have more standardized reference ranges and stronger outcome data.
If salivary DHEA-S runs consistently low alongside other signs (fatigue, low blood pressure, unexplained weight loss, salt cravings), consider an endocrinology consultation to evaluate for adrenal insufficiency, which would also involve cortisol testing and possibly an ACTH stimulation test. Persistently high levels in women with symptoms of androgen excess (acne, unwanted hair growth, irregular periods) warrant evaluation for polycystic ovary syndrome, congenital adrenal hyperplasia, or rare adrenal tumors. Across most patterns, the most useful companion test is cortisol, because the cortisol-to-DHEA-S ratio gives you a balance reading that neither hormone provides alone.
Evidence-backed interventions that affect your Salivary DHEA-S level
DHEA-S is best interpreted alongside these tests.
DHEA-S is included in these pre-built panels.